Aspirin for Primary Prevention of Cardiovascular Events in the Elderly Current Status and Future Directions

The role of aspirin in the secondary prevention of occlusive cardiovascular events has now been well established. Given this, aspirin in primary prevention has been the focus of several large trials and subsequent meta-analyses over the past 3 decades, and yet the issue remains controversial. Recent...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Drugs & aging Ročník 29; číslo 4; s. 251 - 258
Hlavní autori:	Ward, Stephanie A., Demos, Lisa, Workman, Barbara, McNeil, John J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 01.04.2012 Adis International
Predmet:	Aged Aspirin - pharmacology Biological and medical sciences Cardiovascular Diseases - prevention & control Current Opinion Geriatrics/Gerontology Humans Internal Medicine Medical sciences Medicine Medicine & Public Health Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Practice Guidelines as Topic Randomized Controlled Trials as Topic Prasugrel Aspirin Primary Prevention Ischaemic Stroke Ticagrelor Human Prostaglandin-endoperoxide synthase Enzyme Enzyme inhibitor Cardiovascular disease Acetylsalicylic acid Review Antiplatelet agent Non steroidal antiinflammatory agent Prevention Analgesic Primary Antipyretic Oxidoreductases Salicylates Elderly
ISSN:	1170-229X, 1179-1969, 1179-1969
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!